Our Executive Comittee

CEO Vasant Narasimhan (Photo)

Vasant (Vas) Narasimhan, M.D.

Chief Executive Officer

American

Head of Human Resources Steven Baert (Photo)

Steven Baert

Chief People & Organization Officer

Belgian

Chief Digital Officer Bertrand Bodson (Photo)

Bertrand Bodson

Chief Digital Officer

Belgian

President of NIBR James Bradner (Photo)

James (Jay) Bradner, M.D.

President of the Novartis Institutes for BioMedical Research (NIBR)

American

CEO Sandoz Richard Francis (Photo)

Richard Francis

CEO, Sandoz

British

CEO Novartis Pharmaceuticals Paul Hudson (Photo)

Paul Hudson

CEO, Novartis Pharmaceuticals

British

Chief Financial Officer Harry Kirsch (Photo)

Harry Kirsch

Chief Financial Officer

German/Swiss

Group General Counsel Shannon Thyme Klinger (Photo)

Shannon Thyme Klinger

Group General Counsel

American

Global Head of Novartis Technical Operations Steffen Lang (Photo)

Steffen Lang, Ph.D.

Global Head of Novartis Technical Operations

German/Swiss

Chief Ethics, Risk and Compliance Officer Klaus Moosmayer (Photo)

Klaus Moosmayer, Ph.D.

Chief Ethics, Risk and Compliance Officer

German

CEO Novartis Oncology Elizabeth Barrett (Photo)

Susanne Schaffert,1 Ph.D.

CEO, Novartis Oncology

German

Head of Global Drug Development and Chief Medical Officer John Tsai (Photo)

John Tsai, M.D.

Head of Global Drug Development and Chief Medical Officer

American

Head of NBS Robert Weltevreden (Photo)

Robert Weltevreden

Head of Novartis Business Services (NBS)

Dutch

1 Elizabeth (Liz) Barrett stepped down as CEO of Novartis Oncology and as a member of the Executive Committee of Novartis on December 31, 2018.